Clinical Research StudiesNaked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial*,**,*,**
Presented at the Forty-ninth Annual Meeting of the American Association for Vascular Surgery, Baltimore, Md, Jun 12-13, 2001.
Under an Elsevier user license
open archive
Cited by (0)
- *
Funded through a Research Grant from Gencell, Aventis Pharma, Antony, France.
- **
Competition of interest: Drs Comerota and Throm have been paid a consulting fee by Gencell, Aventis Pharma.
- *
.
- **
Reprint requests: Anthony J. Comerota, MD, FACS, Department of Surgery, Temple University School of Medicine, Broad & Ontario Streets, Philadelphia, PA 19140.
Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery. Published by Elsevier Inc. All rights reserved.